Sanofi
SNY
504 hedge funds and large institutions have $9.8B invested in Sanofi in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 126 increasing their positions, 197 reducing their positions, and 53 closing their positions.
98% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $11.3M
4% more funds holding
Funds holding: 484 → 504 (+20)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.14% less ownership
Funds ownership: 9.12% → 8.98% (-0.14%)
36% less repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 197
40% less capital inflows, than outflows
Capital inflows: $288M | Capital outflows: $478M
55% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$53.1M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$19.3M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$13.4M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$9.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$82.1M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$73.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$42.8M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$30M |
| 5 |
Raymond James & Associates
St Petersburg,
Florida
|
-$25.5M |
SNY Hedge Fund Activity: Q4 2017 in Review
504 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2017, worth a combined $9.8B — down 14% from $11.4B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of SNY and 24 opened new positions — a net loss of 29 holders — while 197 trimmed existing stakes and 126 added.
The largest buyer was Fidelity Investments, adding an estimated $90.6M. The largest seller was Bank of America, cutting an estimated $82.1M.
- 504 institutional investors held Sanofi (SNY) as of Q4 2017, up from 484 in Q3 2017.
- Funds reported $9.8B of Sanofi stock for Q4 2017, down 14% quarter-over-quarter.
- 24 funds opened new Sanofi positions in Q4 2017 and 53 closed out, a net change of -29 holders.
- The largest Sanofi buyer in Q4 2017 was Fidelity Investments, an estimated $90.6M added.
- The largest Sanofi seller in Q4 2017 was Bank of America, an estimated $82.1M sold.
Based on aggregated 13F filings for Q4 2017.